Science & Technology
Morquio A therapy integrating gene transfer with lectin-enhanced enzyme delivery to treat multisystemic clinical impairments of rare metabolic childhood diseases
Department of Health and Human Services — National Institutes of Health
Opportunity #: 1R43HD114328-01
Award Ceiling
$296K
Award Floor
$296K
Close Date
Aug 31, 2024
Total Funding
$296K
Expected Awards
1
Posted Date
Sep 20, 2023
Cost Sharing Required
No
Grants.gov ID
sbir-1R43HD114328-01
Description
SBIR Phase Phase I award: "Morquio A therapy integrating gene transfer with lectin-enhanced enzyme delivery to treat multisystemic clinical impairments of rare metabolic childhood diseases" awarded to BIOSTRATEGIES LC in JONESBORO, Arkansas. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $295,923. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses, Socially/economically disadvantaged
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.